After completion of the phase 2 trial should spark licensing or takeover bid
Shares by next year, I couldn't tell.
Huge opportunity here, DXB could change the process of drug manufacturing saving years off research. Very possible to change the way drugs are designed/manufactured/processed. Changing history, saving millions in research and testing. One of my investor friends works in medicine and believes this is the best LT in a long time. I should get him to elaborate and post it here.
After completion of the phase 2 trial should spark licensing or...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.005(1.08%) |
Mkt cap ! $266.8M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 49.0¢ | 46.5¢ | $1.100M | 2.308M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 265425 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 56537 | 6 |
View Market Depth
| Last trade - 13.15pm 29/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |